Medifast (MED) Issues Q4, FY09 Outlook

January 25, 2010 8:07 AM EST Send to a Friend
Medifast (NYSE: MED) sees Q4 EPS of $0.17-$0.20, which compares to the Street estimate of $0.16, on sales of $44.6-$45.6 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login